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Abstract 
Review on t(X;10)( p11;p12), with data on clinics 
and the genes involved. 
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Clinics and pathology 
Disease 
T-Acute lymphoblastic leukemia/lymphoma 
Phenotype/cell stem origin 
In two cases T-ALL was arrested at cortical stage. In 
the other 3 patients, immunophenotype was 
incomplete or not available [Brandimarte et al, 2013, 
2014]. 
Epidemiology 
t(X;10)( p11;p12) DDX3X/MLLT10 occurs in 
approximately 3% of adult T-ALL and characterizes 
a subgroup of NOTCH1 positive leukemias.  
All five T- ALL patients were males 
aged 11 - 38 years (median 24.4 
years). Treatment 
All patients achieved hematologic remission but 3 
relapsed and died. Two patients are alive, one of 
them was treated by HLA identical Hematopoietic 
stem cell transplantation (HSCT). 
Cytogenetics 
Additional anomalies 
see above; notably: del(9p) in 4 cases, del(5q) and 
del(6q) in 1 case. 
Genes involved and 
proteins 
DDX3X (DEAD-box helicase 3, X-
linked) 
Location Xp11.4 
Protein 
DDX3X is a member of the large family of RNA 
helicases with a DEAD box domain that is involved 
in RNA transcription, splicing, mRNA transport, 
translation initiation, and cell-cycle regulation 
[Rosner  et al, 2007]. 
Somatic mutations 
DDX3X somatic mutations have recently been 
discovered in medulloblastoma, chronic 
lymphocytic leukemia, and Burkitt lymphoma. 
Recurrent DDX3X homozygous deletions were 
identified in gingivobuccal oral squamous cell 
carcinoma [Brandimarte L., et al, 2013]. 
MLLT10 (myeloid/lymphoid or mixed-
lineage leukemia (trithorax homolog, 
Drosophila); translocated to, 10) 
Location 10p12.31 
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Pts 
Age, 
gender 
WBC 
(x109/l) 
Immuno-phenotype Karyotype CI-FISH Therapy 
Follow up 
(months) 
1 11, M 152.8 Cortical T-ALL n.a. 
Split: 
MLLT10/10p12 
Loss: PAX5, 
CDKN2A/B, 
Jak2/9p13-24 
Gain: RP11-
501C14/17q21.31 
AIEOP 
LLA 2000 
+73 alive 
[Brandimarte et 
al, 2013] 
2 26, M 88 
Cortical: CD45+, 
cyCD3+, TDT+, 
sCD3+, CD4+, CD5+, 
CD38+, CD1a+, CD34-, 
CD10- 
46,Y,t(X;10)(p1
1;p12),add(1)(p3
6),del(9)(p11p24
)[10]/ 
46,idem,del(6)(q
15)[1]/ 
46,XY[11] 
del(5q)/MAPK9,F
LT4 
del(6)(q15)/CASP
8AP2 
del(9)(p21)/CDKN
2A/B 
GIMEMA 
0904 HLA 
identical 
SCT 
+80 alive   
[Brandimarte et 
al, 2014] 
3 38, M 160 
TDT+, CD7+, cyCD3+, 
CD5+, CD4+, CD8- 
n.a. 
del(9)(p21)/CDKN
2A/B 
GIMEMA 
0904 
Relapse +38 
dead 
[Brandimarte et 
al, 2014] 
4 31, M 700 n.a. 46,XY[20] normal 
GIMEMA 
0904 
Relapse +10 
dead 
[Brandimarte et 
al, 2014] 
5 16, M 68 
CD45+, TDT+, HLA-
DR+, CD7+, CD2+, 
sCD3+, CD5+, CD8+, 
CD19-, CD14-, CD13-, 
CD33-, CD34-, CD22-, 
CD20-, CD4- 
46,XY[20] 
del(9)(p21)/CDKN
2A 
GIMEMA 
0496 
unrelated 
SCT 
Relapse +42 
dead 
[Brandimarte et 
al, 2014] 
 
 
Protein 
MLLT10 contains 3 Zn fingers and a leucine zipper; 
nuclear localisation; transcription factor [Morerio 
and Panarello, 2005] 
Result of the chromosomal anomaly 
Fusion protein 
Oncogenesis 
DDX3X is one of the genes that escapes X-
inactivation in females [Lahn B.T. et  al., 1997]. As 
all patients with DDX3X-MLLT10 positive T-ALL 
were males, no wild-type DDX3X allele was 
retained in the leukemic blasts, suggesting that the 
complete absence of a normally  functional DDX3X 
protein might contribute to leukemogenesis. 
DDX3X appeared to have oncogenic as well as 
tumor supressor functions [Change P.C. et al., 2006; 
Botlagunta M. et al., 2008; Brandimarte L., et al, 
2014]. 
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